Published in J Atten Disord on September 28, 2010
Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry (2014) 1.47
Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA). J Am Acad Child Adolesc Psychiatry (2014) 0.88
Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control. Psychopharmacology (Berl) (2012) 0.87
Obsessive-compulsive disorder and comorbid attention-deficit/hyperactivity disorder: a complex diagnostic disentanglement and treatment. J Child Adolesc Psychopharmacol (2013) 0.75
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58
Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2005) 3.79
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry (2006) 3.68
A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry (2004) 3.44
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry (2008) 3.30
National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry (2003) 3.07
Validation of proposed DSM-5 criteria for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry (2011) 2.72
Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol (2006) 2.64
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 2.63
Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2007) 2.49
Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know? Psychiatr Serv (2007) 2.41
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30
Interventions for adolescent depression in primary care. Pediatrics (2006) 2.28
National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry (2002) 2.22
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics (2009) 2.13
Growing evidence to support early intervention in early onset bipolar disorder. Aust N Z J Psychiatry (2007) 2.09
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Improving recognition of adolescent depression in primary care. Arch Pediatr Adolesc Med (2006) 1.92
Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther (2006) 1.92
Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry (2007) 1.82
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics (2007) 1.82
Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. Am J Psychiatry (2009) 1.82
Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord (2005) 1.78
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.70
Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull (2007) 1.69
Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients. J Am Acad Child Adolesc Psychiatry (2005) 1.69
Comparison of public attributions, attitudes, and stigma in regard to depression among children and adults. Psychiatr Serv (2007) 1.66
The organizational social context of mental health services and clinician attitudes toward evidence-based practice: a United States national study. Implement Sci (2012) 1.65
Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents. J Clin Psychiatry (2006) 1.64
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatry (2003) 1.63
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study. J Am Acad Child Adolesc Psychiatry (2012) 1.62
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry (2002) 1.60
Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord (2008) 1.59
Gender differences in criminality: bipolar disorder with co-occurring substance abuse. J Am Acad Psychiatry Law (2005) 1.59
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health (2009) 1.58
Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents. J Clin Psychiatry (2008) 1.58
Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings. Bipolar Disord (2005) 1.56
Public knowledge and assessment of child mental health problems: findings from the National Stigma Study-Children. J Am Acad Child Adolesc Psychiatry (2008) 1.53
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct (2010) 1.51
Toward an evidence-based assessment of pediatric bipolar disorder. J Clin Child Adolesc Psychol (2005) 1.50
Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years. J Am Acad Child Adolesc Psychiatry (2004) 1.48
Barriers to the identification and management of psychosocial issues in children and maternal depression. Pediatrics (2007) 1.48
Discriminative validity of a parent version of the Young Mania Rating Scale. J Am Acad Child Adolesc Psychiatry (2002) 1.48
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry (2007) 1.48
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, assessment, and initial management. Pediatrics (2007) 1.48
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results. J Clin Psychiatry (2010) 1.47
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol (2003) 1.46
Guns, adolescents, and mental illness. Am J Psychiatry (2008) 1.46
Internal consistency and associated characteristics of informant discrepancies in clinic referred youths age 11 to 17 years. J Clin Child Adolesc Psychol (2011) 1.46
Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol (2002) 1.45
Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder. Psychiatr Serv (2007) 1.41
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41
Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry (2004) 1.40
Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry (2005) 1.39
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry (2003) 1.39
International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol (2004) 1.38
Disseminating child & adolescent mental health treatment methods: an international feasibility study. Rev Bras Psiquiatr (2006) 1.37
Training of evidence-based assessment and intervention approaches in cross-cultural contexts: challenges and solutions. Rev Bras Psiquiatr (2006) 1.36
Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. J Am Acad Child Adolesc Psychiatry (2007) 1.36
Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2004) 1.34
Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry (2006) 1.34
Development of adaptable and flexible treatment manuals for externalizing and internalizing disorders in children and adolescents. Rev Bras Psiquiatr (2006) 1.32
Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31
Reliability of the services for children and adolescents-parent interview. J Am Acad Child Adolesc Psychiatry (2004) 1.31
Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda. J Clin Psychiatry (2006) 1.31
A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics (2002) 1.28
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry (2004) 1.27
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.27
Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol (2002) 1.26
Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J Clin Psychiatry (2011) 1.25
Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry (2012) 1.23
Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry (2002) 1.23
Who are the comorbid adolescents? Agreement between psychiatric diagnosis, youth, parent, and teacher report. J Abnorm Child Psychol (2003) 1.23
The Application of Behavior Change Theory to Family-Based Services: Improving Parent Empowerment in Children's Mental Health. J Child Fam Stud (2010) 1.23
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol (2007) 1.21
Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord (2010) 1.21
Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utility. J Child Adolesc Psychopharmacol (2003) 1.18
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry (2012) 1.18
Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disord (2010) 1.15
AACAP 2001 research forum: challenges and recommendations regarding recruitment and retention of participants in research investigations. J Am Acad Child Adolesc Psychiatry (2004) 1.15
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol (2003) 1.15
Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness. Psychiatr Serv (2007) 1.13
Review of safety assessment methods used in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2003) 1.13
Effects of adolescent manic symptoms on agreement between youth, parent, and teacher ratings of behavior problems. J Affect Disord (2004) 1.13
How can we improve the assessment of safety in child and adolescent psychopharmacology? J Am Acad Child Adolesc Psychiatry (2003) 1.12
Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. J Can Acad Child Adolesc Psychiatry (2006) 1.12
Mental health assessments in juvenile justice: report on the consensus conference. J Am Acad Child Adolesc Psychiatry (2003) 1.11
Risperidone in the management of disruptive behavior disorders. J Child Adolesc Psychopharmacol (2006) 1.11
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol (2003) 1.10
A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry (2006) 1.10